{"id":"https://openalex.org/W4292401005","doi":"https://doi.org/10.1128/aac.02385-21","title":"Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing","display_name":"Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing","publication_year":2022,"publication_date":"2022-08-09","ids":{"openalex":"https://openalex.org/W4292401005","doi":"https://doi.org/10.1128/aac.02385-21","pmid":"https://pubmed.ncbi.nlm.nih.gov/35943252","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9487628"},"language":"en","primary_location":{"id":"doi:10.1128/aac.02385-21","doi":"https://doi.org/10.1128/aac.02385-21","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.02385-21","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9487628/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111408504","display_name":"Michelle M. Pham","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle M. Pham","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000852039","display_name":"Anthony T. Podany","orcid":"https://orcid.org/0000-0002-8371-0379","observed_orcids":["https://orcid.org/0000-0002-8371-0379"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony T. Podany","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083035273","display_name":"Noluthando Mwelase","orcid":"https://orcid.org/0000-0002-8189-6149","observed_orcids":["https://orcid.org/0000-0002-8189-6149"]},"institutions":[{"id":"https://openalex.org/I192619145","display_name":"University of the Witwatersrand","ror":"https://ror.org/03rp50x72","country_code":"ZA","type":"education","lineage":["https://openalex.org/I192619145"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Noluthando Mwelase","raw_affiliation_strings":["University of the Witwatersrand Helen Joseph CRS, Johannesburg, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of the Witwatersrand Helen Joseph CRS, Johannesburg, South Africa","institution_ids":["https://openalex.org/I192619145"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032814621","display_name":"Khuanchai Supparatpinyo","orcid":"https://orcid.org/0000-0003-1838-4826","observed_orcids":["https://orcid.org/0000-0003-1838-4826"]},"institutions":[{"id":"https://openalex.org/I48076826","display_name":"Chiang Mai University","ror":"https://ror.org/05m2fqn25","country_code":"TH","type":"education","lineage":["https://openalex.org/I48076826"]}],"countries":["TH"],"is_corresponding":false,"raw_author_name":"Khuanchai Supparatpinyo","raw_affiliation_strings":["Chiang Mai University, Chiang Mai, Thailand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chiang Mai University, Chiang Mai, Thailand","institution_ids":["https://openalex.org/I48076826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086244171","display_name":"Lerato Mohapi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149742","display_name":"Perinatal HIV Research Unit","ror":"https://ror.org/05j6xkp39","country_code":"ZA","type":"nonprofit","lineage":["https://openalex.org/I4210149742"]}],"countries":["ZA"],"is_corresponding":false,"raw_author_name":"Lerato Mohapi","raw_affiliation_strings":["Soweto ACTG CRS, Perinatal HIV Research Unit, Johannesburg, South Africa"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Soweto ACTG CRS, Perinatal HIV Research Unit, Johannesburg, South Africa","institution_ids":["https://openalex.org/I4210149742"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005879554","display_name":"Amita Gupta","orcid":"https://orcid.org/0000-0001-7036-2718","observed_orcids":["https://orcid.org/0000-0001-7036-2718"]},"institutions":[{"id":"https://openalex.org/I4210150714","display_name":"Johns Hopkins Hospital","ror":"https://ror.org/05cb1k848","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210150714"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amita Gupta","raw_affiliation_strings":["Johns Hopkins Hospital, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins Hospital, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I4210150714"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038527599","display_name":"Wadzanai P. Samaneka","orcid":"https://orcid.org/0009-0005-6636-0396","observed_orcids":["https://orcid.org/0009-0005-6636-0396","https://orcid.org/0000-0003-0215-9309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wadzanai Samaneka","raw_affiliation_strings":["Milton Park CRS, Harare, Zimbabwe"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Milton Park CRS, Harare, Zimbabwe","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053987417","display_name":"Ayotunde Omoz-Oarhe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ayotunde Omoz-Oarhe","raw_affiliation_strings":["Molepolole Clinical Research Site, Molepolole, Botswana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molepolole Clinical Research Site, Molepolole, Botswana","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024983758","display_name":"Deborah Langat","orcid":"https://orcid.org/0000-0003-0439-1099","observed_orcids":["https://orcid.org/0000-0003-0439-1099"]},"institutions":[{"id":"https://openalex.org/I2841861","display_name":"Kenya Medical Research Institute","ror":"https://ror.org/04r1cxt79","country_code":"KE","type":"facility","lineage":["https://openalex.org/I2841861"]}],"countries":["KE"],"is_corresponding":false,"raw_author_name":"Deborah Langat","raw_affiliation_strings":["Kenya Medical Research Institute/Walter Reed Project Clinical Research Center CRS, Kericho, Kenya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kenya Medical Research Institute/Walter Reed Project Clinical Research Center CRS, Kericho, Kenya","institution_ids":["https://openalex.org/I2841861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078117679","display_name":"Constance Ann Benson","orcid":"https://orcid.org/0000-0002-3781-1347","observed_orcids":["https://orcid.org/0000-0002-3781-1347"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Constance A. Benson","raw_affiliation_strings":["University of California San Diego, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego, San Diego, California, USA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071106707","display_name":"Richard E. Chaisson","orcid":"https://orcid.org/0000-0003-4710-925X","observed_orcids":["https://orcid.org/0000-0003-4710-925X"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard E. Chaisson","raw_affiliation_strings":["Johns Hopkins University School of Medicine, Center for Tuberculosis Research, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University School of Medicine, Center for Tuberculosis Research, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045831486","display_name":"Susan Swindells","orcid":"https://orcid.org/0000-0001-5826-6037","observed_orcids":["https://orcid.org/0000-0001-5826-6037"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Swindells","raw_affiliation_strings":["Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017051528","display_name":"Courtney Vail Fletcher","orcid":"https://orcid.org/0000-0002-3703-7849","observed_orcids":["https://orcid.org/0000-0002-3703-7849"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Courtney V. Fletcher","raw_affiliation_strings":["Antiviral Pharmacology Laboratory, UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA","Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA"],"raw_orcid":"https://orcid.org/0000-0002-3703-7849","affiliations":[{"raw_affiliation_string":"Antiviral Pharmacology Laboratory, UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA","institution_ids":["https://openalex.org/I59130452"]},{"raw_affiliation_string":"Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA","institution_ids":["https://openalex.org/I59130452"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5017051528"],"corresponding_institution_ids":["https://openalex.org/I59130452"],"apc_list":null,"apc_paid":null,"fwci":0.6464,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.60246635,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"66","issue":"9","first_page":"e0238521","last_page":"e0238521"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.3831000030040741,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.3831000030040741,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.1931000053882599,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.17520000040531158,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rifapentine","display_name":"rifapentine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/population-pharmacokinetic-model","display_name":"population pharmacokinetic model","score":0.828000009059906},{"id":"https://openalex.org/keywords/efavirenz","display_name":"efavirenz","score":0.7910000085830688},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.847000002861023},{"id":"https://openalex.org/keywords/weight-based-dosing","display_name":"weight-based dosing","score":0.7820000052452087},{"id":"https://openalex.org/keywords/tuberculosis-prevention","display_name":"tuberculosis prevention","score":0.6830000281333923},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.6959999799728394},{"id":"https://openalex.org/keywords/isoniazid","display_name":"isoniazid","score":0.9380000233650208},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7129999995231628},{"id":"https://openalex.org/keywords/pharmacokinetic-simulation","display_name":"pharmacokinetic simulation","score":0.6259999871253967}],"concepts":[{"id":"https://openalex.org/C2776991065","wikidata":"https://www.wikidata.org/wiki/Q3935297","display_name":"Rifapentine","level":5,"score":0.9915391206741333},{"id":"https://openalex.org/C2781432083","wikidata":"https://www.wikidata.org/wiki/Q422645","display_name":"Efavirenz","level":5,"score":0.7766050100326538},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.731105625629425},{"id":"https://openalex.org/C2776967927","wikidata":"https://www.wikidata.org/wiki/Q423169","display_name":"Isoniazid","level":3,"score":0.6998014450073242},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6843070983886719},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6756028532981873},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.624250590801239},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.5890191197395325},{"id":"https://openalex.org/C2776239304","wikidata":"https://www.wikidata.org/wiki/Q6954915","display_name":"NONMEM","level":3,"score":0.5293092727661133},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.522310197353363},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5034410357475281},{"id":"https://openalex.org/C2776306059","wikidata":"https://www.wikidata.org/wiki/Q388565","display_name":"Rifamycin","level":3,"score":0.4677565097808838},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.314388632774353},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.29435163736343384},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.2850593328475952},{"id":"https://openalex.org/C2779806340","wikidata":"https://www.wikidata.org/wiki/Q4254929","display_name":"Latent tuberculosis","level":4,"score":0.27443909645080566},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.24692347645759583},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.12682348489761353},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.10912209749221802},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.10481375455856323},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.08157458901405334},{"id":"https://openalex.org/C2777975735","wikidata":"https://www.wikidata.org/wiki/Q130971","display_name":"Mycobacterium tuberculosis","level":3,"score":0.07434442639350891},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000480","descriptor_name":"Alkynes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007538","descriptor_name":"Isoniazid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012293","descriptor_name":"Rifampin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D019829","descriptor_name":"Nevirapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D048588","descriptor_name":"Benzoxazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1128/aac.02385-21","doi":"https://doi.org/10.1128/aac.02385-21","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.02385-21","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmid:35943252","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35943252","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9487628","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9487628/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:9487628","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9487628/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G365533939","display_name":"AIDS Clinical Trials Group Network","funder_award_id":"U01AI068636","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G3833284436","display_name":"Clinical Pharmacology of Efavirenz Combined with High Dose Rifapentine","funder_award_id":"K23AI134307","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G6258373279","display_name":"UZ-UCSF Clinical Trials Unit","funder_award_id":"U01AI069436","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000857907","display_name":"UZ-UCSF CTU","funder_award_id":"UM1AI069436","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000859447","display_name":"UCSD Collaborative Clinical Trials Unit","funder_award_id":"UM1AI069432","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000863735","display_name":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","funder_award_id":"UM1AI068636","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000872138","display_name":"Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU","funder_award_id":"UM1AI069456","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000884504","display_name":"AIDS Clinical Trial Group Laboratory Center","funder_award_id":"UM1AI106701","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000886520","display_name":"Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG)","funder_award_id":"UM1AI068634","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000891668","display_name":"Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU)","funder_award_id":"UM1AI069465","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000895809","display_name":"University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit","funder_award_id":"UM1AI069423","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000900422","display_name":"Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)","funder_award_id":"UM1AI069399","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000910744","display_name":"Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication","funder_award_id":"UM1AI069463","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000919591","display_name":"PHRU-Setshaba Clinical Trials Unit","funder_award_id":"UM1AI069453","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1574223199","https://openalex.org/W1969922063","https://openalex.org/W1989525615","https://openalex.org/W1992500936","https://openalex.org/W2064745571","https://openalex.org/W2066464642","https://openalex.org/W2091569420","https://openalex.org/W2109242366","https://openalex.org/W2114609571","https://openalex.org/W2130673871","https://openalex.org/W2155898568","https://openalex.org/W2921307586","https://openalex.org/W3024961108","https://openalex.org/W3045676066","https://openalex.org/W3067695085","https://openalex.org/W3109675346"],"related_works":["https://openalex.org/W3024961108","https://openalex.org/W1969922063","https://openalex.org/W2898814428","https://openalex.org/W4416292413","https://openalex.org/W2493897159","https://openalex.org/W7196960985","https://openalex.org/W2114609571","https://openalex.org/W3109675346","https://openalex.org/W7032664028","https://openalex.org/W1990770714"],"abstract_inverted_index":{"The":[0],"Brief":[1],"Rifapentine\u2013Isoniazid":[2],"Efficacy":[3],"for":[4,25],"TB":[5,27],"Prevention/A5279":[6],"trial":[7,42],"demonstrated":[8],"a":[9,57],"1-month":[10],"daily":[11],"regimen":[12],"of":[13,22],"rifapentine":[14,39,54],"and":[15,48],"isoniazid":[16,23],"was":[17,36],"noninferior":[18],"to":[19,37,51],"9":[20],"months":[21],"alone":[24],"preventing":[26],"in":[28,41],"persons":[29],"living":[30],"with":[31,56],"HIV":[32],"(PLWH).":[33],"Our":[34],"objective":[35],"evaluate":[38],"pharmacokinetics":[40],"participants":[43],"receiving":[44],"antiretroviral":[45],"therapy":[46],"(ART)":[47],"perform":[49],"simulations":[50],"compare":[52],"weight-based":[53],"dosing":[55],"standard,":[58],"fixed":[59],"dose.":[60]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-08-20T00:00:00"}